141 related articles for article (PubMed ID: 35406868)
1. Characterization of Promising Cytotoxic Metabolites from
El-Hawary SS; Mohammed R; Taher MA; AbouZid SF; Mansour MA; Almahmoud SA; Huwaimel B; Amin E
Plants (Basel); 2022 Mar; 11(7):. PubMed ID: 35406868
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of cytotoxic metabolites from five Tabebuia species supported by molecular correlation analysis.
El-Hawary SS; Mohammed R; Tawfike AF; AbouZid SF; Taher MA; Abdelmohsen UR; Amin E
Sci Rep; 2021 Apr; 11(1):8405. PubMed ID: 33863934
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
PLoS One; 2021; 16(7):e0254035. PubMed ID: 34260631
[TBL] [Abstract][Full Text] [Related]
5. Molecular Interaction and Computational Analytical Studies of Pinocembrin for its Antiangiogenic Potential Targeting VEGFR-2: A Persuader of Metastasis.
Sharma N; Sharma M; Shakeel E; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM; Akhtar S
Med Chem; 2018; 14(6):626-640. PubMed ID: 29663896
[TBL] [Abstract][Full Text] [Related]
6. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
7. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
[TBL] [Abstract][Full Text] [Related]
8. Target fishing of glycopentalone using integrated inverse docking and reverse pharmacophore mapping approach.
Gurung AB; Ali MA; Bhattacharjee A; Al-Anazi KM; Farah MA; Al-Hemaid FM; Abou-Tarboush FM; Lee J; Kim SY; Al-Anazi FS
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525951
[TBL] [Abstract][Full Text] [Related]
9. Unfolding the apoptotic mechanism of antioxidant enriched-leaves of Tabebuia pallida (lindl.) miers in EAC cells and mouse model.
Rahman MM; Reza ASMA; Khan MA; Sujon KM; Sharmin R; Rashid M; Sadik MG; Reza MA; Tsukahara T; Capasso R; Mosaddik A; Gobe GC; Alam AK
J Ethnopharmacol; 2021 Oct; 278():114297. PubMed ID: 34118341
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation.
Marzouk AA; Abdel-Aziz SA; Abdelrahman KS; Wanas AS; Gouda AM; Youssif BGM; Abdel-Aziz M
Bioorg Chem; 2020 Sep; 102():104090. PubMed ID: 32683176
[TBL] [Abstract][Full Text] [Related]
12. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma.
Eissa IH; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; Abdelhady AA; Elhendawy MA; Radwan MM; ElSohly MA; Mahdy HA
Bioorg Chem; 2021 Feb; 107():104532. PubMed ID: 33334586
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory mechanism of O-methylated quercetins, highly potent β-secretase inhibitors isolated from Caragana balchaschensis (Kom.) Pojark.
Zhumanova K; Lee G; Baiseitova A; Shah AB; Kim JH; Kim JY; Lee KW; Park KH
J Ethnopharmacol; 2021 May; 272():113935. PubMed ID: 33609726
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of gallic acid and quercetin derived from
Sachithanandam V; Parthiban A; Lalitha P; Muthukumaran J; Jain M; Elumalai D; Jayabal K; Sridhar R; Ramachandran P; Ramachandran R
J Biomol Struct Dyn; 2022 Mar; 40(4):1490-1502. PubMed ID: 32996435
[TBL] [Abstract][Full Text] [Related]
15. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
16. Phytoconstituents,
Youssef FS; Altyar AE; Omar AM; Ashour ML
Front Pharmacol; 2021; 12():619373. PubMed ID: 33912041
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.
Allaka TR; Katari NK; Jonnalagadda SB; Malkhed V; Anireddy JS
Curr Drug Discov Technol; 2021; 18(6):e130921187682. PubMed ID: 33155923
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation.
Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K
Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.
El-Adl K; Sakr HM; Yousef RG; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Abulkhair HS; Eissa IH
Bioorg Chem; 2021 Sep; 114():105105. PubMed ID: 34175720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
